Eagye et al. (2009)
|
Meropenem resistant P. aeruginosa (58)
|
Median total cost (IQR)
|
$100,704 ($27,710 – $183,125)
|
< 0.001
|
[53]
|
Meropenem susceptible P. aeruginosa (125)
|
$32,594 ($13,112 – $100,702)
|
Meropenem resistant P. aeruginosa (58)
|
$100,704 ($27,710 – $183,125)
|
< 0.001
|
Control (57)
|
$25,744 ($17,456 – $40,616)
|
Evans et al. (2007)
|
Susceptible P. aeruginosa (73)
|
Median total cost (IQR)
|
$99,672 ($43,714 – $187,260
|
0.015
|
[71]
|
Resistant P. aeruginosaa (47)
|
$69,502 ($24,853 – $113,933)
|
Gasink et al. (2006)
|
Fluoroquinolone resistant P. aeruginosa (320)
|
Median total charges (IQR)*
|
$62,325 ($22,129 - $188,979)
|
0.008
|
[64]
|
Fluoroquinolone susceptible P. aeruginosa (527)
|
$48,733 ($18,760 - $124,820)
|
Lautenbach et al. (2010)
|
Imipenem resistant P. aeruginosa (253)
|
Mean hospital cost after culture sampling (95% CI)
|
$286,417 ($234,326 – $338,510)
|
< 0.001
|
[63]
|
Imipenem susceptible P. aeruginosa (2289)
|
$189,274 ($172,428 – $206,121)
|
Morales et al. (2012)
|
MDR P. aeruginosab (134)
|
Mean hospital cost after culture sampling (median)
|
$13,178 ($5,745)
|
< 0.001†
|
[49]
|
Susceptible P. aeruginosa (149)
|
$4,258 ($2,420)
|
Resistant P. aeruginosa (119)
|
$10,662 ($5,248)
|
< 0.001†
|
Susceptible P. aeruginosa (149)
|
$4,258 ($2,420)
|